Can novel therapeutics halt the amyloid cascade?

por Prins, Niels D, Visser, Pieter Jelle, Scheltens, Philip
Publicado 2010

Data and sample sharing as an enabler for large-scale biomarker research and development: The EPND perspective

por Bose, Niranjan, Brookes, Anthony J., Scordis, Phil, Visser, Pieter Jelle
Publicado 2022

Retinal thickness in Alzheimer's disease: A systematic review and meta-analysis

por den Haan, Jurre, Verbraak, Frank D., Visser, Pieter Jelle, Bouwman, Femke H.
Publicado 2017

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

por Bertens, Daniela, Tijms, Betty M., Scheltens, Philip, Teunissen, Charlotte E., Visser, Pieter Jelle
Publicado 2017

The effect of diagnostic criteria on outcome measures in preclinical and prodromal Alzheimer's disease: Implications for trial design

por Bertens, Daniela, Tijms, Betty M., Vermunt, Lisa, Prins, Niels D., Scheltens, Philip, Visser, Pieter Jelle
Publicado 2017

Research diagnostic criteria for Alzheimer’s disease: findings from the LipiDiDiet randomized controlled trial

por Rosenberg, Anna, Solomon, Alina, Soininen, Hilkka, Visser, Pieter Jelle, Blennow, Kaj, Hartmann, Tobias, Kivipelto, Miia
Publicado 2021

24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial

por Soininen, Hilkka, Solomon, Alina, Visser, Pieter Jelle, Hendrix, Suzanne B, Blennow, Kaj, Kivipelto, Miia, Hartmann, Tobias
Publicado 2017

36‐month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease

por Soininen, Hilkka, Solomon, Alina, Visser, Pieter Jelle, Hendrix, Suzanne B, Blennow, Kaj, Kivipelto, Miia, Hartmann, Tobias
Publicado 2020

Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal

por Vermunt, Lisa, van Paasen, Alegría J.L., Teunissen, Charlotte E., Scheltens, Philip, Visser, Pieter Jelle, Tijms, Betty M.
Publicado 2019

CSF proteomic signature predicts progression to Alzheimer's disease dementia

por Vromen, Eleonora M., del Campo Milán, Marta, Scheltens, Philip, Teunissen, Charlotte E., Visser, Pieter Jelle, Tijms, Betty M.
Publicado 2022

Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer’s disease biomarkers

por Weiner, Sophia, Sauer, Mathias, Visser, Pieter Jelle, Tijms, Betty M., Vorontsov, Egor, Blennow, Kaj, Zetterberg, Henrik, Gobom, Johan
Publicado 2022

Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease

por Dicks, Ellen, Vermunt, Lisa, van der Flier, Wiesje M., Visser, Pieter Jelle, Barkhof, Frederik, Scheltens, Philip, Tijms, Betty M.
Publicado 2019

Magnetoencephalography Brain Signatures Relate to Cognition and Cognitive Reserve in the Oldest-Old: The EMIF-AD 90 + Study

por Griffa, Alessandra, Legdeur, Nienke, Badissi, Maryam, van den Heuvel, Martijn P., Stam, Cornelis J., Visser, Pieter Jelle, Hillebrand, Arjan
Publicado 2021

Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid

por Voyle, Nicola, Patel, Hamel, Folarin, Amos, Newhouse, Stephen, Johnston, Caroline, Visser, Pieter Jelle, Dobson, Richard J.B., Kiddle, Steven J.
Publicado 2016

Finding Treatment Effects in Alzheimer Trials in the Face of Disease Progression Heterogeneity

por Jutten, Roos J., Sikkes, Sietske A.M., Van der Flier, Wiesje M., Scheltens, Philip, Visser, Pieter Jelle, Tijms, Betty M.
Publicado 2021

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment

por ten Kate, Mara, Barkhof, Frederik, Visser, Pieter Jelle, Teunissen, Charlotte E., Scheltens, Philip, van der Flier, Wiesje M., Tijms, Betty M.
Publicado 2017

The association of vascular disorders with incident dementia in different age groups

por Legdeur, Nienke, van der Lee, Sven J., de Wilde, Marcel, van der Lei, Johan, Muller, Majon, Maier, Andrea B., Visser, Pieter Jelle
Publicado 2019

Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease

por Babapour Mofrad, Rosha, Schoonenboom, Niki S.M., Tijms, Betty M., Scheltens, Philip, Visser, Pieter Jelle, van der Flier, Wiesje M., Teunissen, Charlotte E.
Publicado 2018

Time from diagnosis to institutionalization and death in people with dementia

por Joling, Karlijn J., Janssen, Olin, Francke, Anneke L., Verheij, Robert A., Lissenberg‐Witte, Birgit I., Visser, Pieter‐Jelle, van Hout, Hein P.J.
Publicado 2020

Is the association between blood pressure and cognition in the oldest-old modified by physical, vascular or brain pathology markers? The EMIF-AD 90 + Study

por Legdeur, Nienke, Moonen, Justine E., Badissi, Maryam, Sudre, Carole H., Pelkmans, Wiesje, Gordon, Mark Forrest, Barkhof, Frederik, Peters, Mike, Visser, Pieter Jelle, Muller, Majon
Publicado 2023